Hypoactive Sexual Desire Disorder (HSDD) Background information for medical media outside the US only This selection gives an overview on background material for HIV/AIDS available on the Boehringer Ingelheim corporate website.

News Releases

• 16.11.2009Flibanserin Demonstrates Efficacy and Tolerability in Pivotal Phase III Trials in Pre-Menopausal Women with Hypoactive Sexual Desire Disorder (HSDD)
• 03 May 2009The Decreased Sexual Desire Screener (DSDS) could benefit millions of women affected by the most common form of female sexual dysfunction, HSDD, which affects nearly one in ten women
• 31 October 2008Largest study of its kind reveals low sexual desire is most common female sexual problem
• 07 May 2008Women suffering from Decreased Sexual Desire: Silence hinders diagnosis of the prevalent condition Hypoactive Sexual Desire Disorder(HSDD)
• news release archive

Documents

• Backgrounder: Female Sexual Dysfunction and Hypoactive Sexual Desire Disorder - November 2009 - PDF (111 KB)
• Backgrounder: The Bouquet® Studies - November 2009 - PDF (227 KB)
• Backgrounder: Flibanserin - November 2009 - PDF (58 KB)
• Backgrounder: Hypoactive Sexual Desire Disorder (for non-US Media only) - May 2008 - PDF (101 KB)